Close Menu

Sage Bionetworks’ Stephen Friend lists at Xcomony five technologies that he thinks “will be relegated to museum displays in the next five (OK, maybe 10) years.” That list includes genome-wide association studies, proteomics as an “end approach” to studying disease, and “hunter-gatherer approaches” in which researchers collect clinical and genomic data from a large group, such as the Framingham cohort, to analyze themselves.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.